Literature DB >> 16542710

Gastrointestinal bleeding in von Willebrand disease.

Michael Makris1.   

Abstract

Gastrointestinal bleeding due to colonic angiodysplasia is a well-recognised complication of von Willebrand disease (vWD), occurring almost exclusively in subtypes of the disease associated with a reduction in high-molecular-weight (HMW) multimers of von Willebrand factor (vWF). A deficiency of vWF HMW multimers also provides the link between aortic stenosis and gastrointestinal (GI) bleeding in Heyde's syndrome. The diagnosis and treatment of the angiodysplastic bleeding in vWD can be very difficult and the role of vWF containing concentrates in treatment and prophylaxis remains to be established.

Entities:  

Mesh:

Year:  2006        PMID: 16542710     DOI: 10.1016/j.thromres.2006.01.022

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  13 in total

Review 1.  Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.

Authors:  Piercarla Schinco; Giancarlo Castaman; Antonio Coppola; Dorina Cultrera; Cosimo Ettorre; Anna C Giuffrida; Emanuela Marchesini; Renato Marino; Marta Milan; Claudio Molinari; Simona M Siboni; Ezio Zanon; Augusto B Federici
Journal:  Blood Transfus       Date:  2017-05-26       Impact factor: 3.443

Review 2.  Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.

Authors:  Soundarya Selvam; Paula James
Journal:  Semin Thromb Hemost       Date:  2017-05-05       Impact factor: 4.180

3.  Massive jejunal bleeding due to Heyde syndrome successfully treated with double balloon endoscopy.

Authors:  Sakiko Ohta; Tomohiro Watanabe; Shuko Morita; Satoru Ueno; Yoshihisa Tsuji; Hiroshi Nakase; Tsutomu Chiba
Journal:  Clin J Gastroenterol       Date:  2009-03-19

4.  Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

Authors:  E Berntorp; B Fuchs; M Makris; R Montgomery; V Flood; J S O'Donnell; A B Federici; D Lillicrap; P James; U Budde; M Morfini; P Petrini; S Austin; C Kannicht; V Jiménez-Yuste; C Lee
Journal:  Haemophilia       Date:  2013-03       Impact factor: 4.287

Review 5.  von Willebrand factor regulation of blood vessel formation.

Authors:  Anna M Randi; Koval E Smith; Giancarlo Castaman
Journal:  Blood       Date:  2018-06-04       Impact factor: 22.113

6.  Characterization of a Porcine Model for Von Willebrand Disease Type 1 and 3 Regarding Expression of Angiogenic Mediators in the Nonpregnant Female Reproductive Tract.

Authors:  Hanna Allerkamp; Stefanie Lehner; Mahnaz Ekhlasi-Hundrieser; Carsten Detering; Christiane Pfarrer; Mario von Depka Prondzinski
Journal:  Comp Med       Date:  2019-09-16       Impact factor: 0.982

Review 7.  Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis.

Authors:  Marcus Stockschlaeder; Reinhard Schneppenheim; Ulrich Budde
Journal:  Blood Coagul Fibrinolysis       Date:  2014-04       Impact factor: 1.276

Review 8.  Current and Emerging Options for the Management of Inherited von Willebrand Disease.

Authors:  Jessica M Heijdra; Marjon H Cnossen; Frank W G Leebeek
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

Review 9.  New Developments in Diagnosis and Management of Acquired Hemophilia and Acquired von Willebrand Syndrome.

Authors:  Frank W G Leebeek
Journal:  Hemasphere       Date:  2021-06-01

Review 10.  Von Willebrand factor, angiodysplasia and angiogenesis.

Authors:  Anna M Randi; Mike A Laffan; Richard D Starke
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.